Fluoxetina, topiramato y combinación de ambos en el control de la conducta alimentaria antes de la cirugía bariátrica

Guisado Macías, Juan A; Méndez Sánchez, Fabiola; Baltasar Tello, Itziar; Zamora Rodríguez, Francisco J; Escudero Sánchez, Ana B; Vaz Leal, Francisco J.
Actas esp. psiquiatr ; 44(3): 93-96, mayo-jun. 2016. tab
Artículo en Español | IBECS (España) | ID: ibc-152885

Documentos relacionados

  1. Therapeutic drug monitoring in pregnancy: Levetiracetam.
  2. Population pharmacokinetics and dosing optimization of perampanel in children with epilepsy: A real-world study.
  3. Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options.
  4. Reduction in anti-seizure medications use in pediatric patients with pharmacoresistant epilepsy submitted to surgical treatment.
  5. Seizures in trisomy 18: Prevalence, description, and treatment.
  6. Effects of CYP2C19 genetic polymorphisms on the pharmacokinetics of lacosamide in Korean patients with epilepsy.
  7. Population Pharmacokinetics of Topiramate in Patients with Epilepsy Using Nonparametric Modeling.
  8. Antiepileptic drug withdrawal in juvenile myoclonic epilepsy.
  9. Pharmacokinetic Variability and Clinical Use of Lacosamide in Children and Adolescents in Denmark and Norway.
  10. Bridged bicyclic compounds: Comprehending a novel compound class as potential anti-seizure agents.